Epidemiology and Prospects for Prevention of Pancreatic Cancer

Reference work entry

Abstract

Pancreatic cancer, although infrequent, has a very poor prognosis, making it currently one of the fourth or fifth most common causes of cancer mortality in developed countries. Its incidence varies greatly across regions, which suggests that lifestyle factors play an important role in its etiology. Because pancreatic cancer is strongly age dependent, increasing population longevity and aging will lead to an increase of the global burden of pancreatic cancer in the coming decades. In fact, pancreatic cancer is anticipated to move from the fourth to the second leading cause of cancer death in the United States by 2020, despite stable age-specific and age-standardized incidence rates. The increase in pancreatic cancer incidence and mortality rates reported in some countries could be largely ascribed to improvement in the diagnosis and ascertainment of the disease, particularly in elderly subjects. The etiology of pancreatic cancer has been extensively studied and has been the subject of numerous meta-analyses and pooled analyses. Using a comprehensive strategy, one can retrieve more than 170 meta-analytical or pooled reports dealing with the association between more than 50 specific risk factors and pancreatic cancer risk. About two-thirds of the major risk factors associated with pancreatic cancer are potentially modifiable, affording a unique opportunity for preventing one of our deadliest cancers: Abstaining from smoking, limiting alcohol intake, adopting a healthy diet, rich in fruits and vegetables, limiting red meat consumption and being physically active in everyday life could reduce pancreas cancer risk by 30 percent.

Keywords

Pancreatic cancer Epidemiology Time trends Etiology Risk factors Diagnostic practice Aging Preventable fraction Prevention 

References

  1. 1.
    Rishi A, Goggins M, Wood LD, Hruban RH. Pathological and molecular evaluation of pancreatic neoplasms. Semin Oncol. 2015;42:28–39.  https://doi.org/10.1053/j.seminoncol.2014.12.004.CrossRefPubMedGoogle Scholar
  2. 2.
    Fesinmeyer MD, Austin MA, Li CI, De Roos AJ, Bowen DJ. Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev. 2005;14:1766–73.CrossRefGoogle Scholar
  3. 3.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.  https://doi.org/10.3322/caac.21262.CrossRefPubMedGoogle Scholar
  4. 4.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.  https://doi.org/10.3322/caac.21332.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Weir HK, Thompson TD, Soman A, Møller B, Leadbetter S. The past, present, and future of cancer incidence in the United States: 1975 through 2020. Cancer. 2015;121:1827–37.  https://doi.org/10.1002/cncr.29258.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Thun M, Peto R, Boreham J, Lopez AD. Stages of the cigarette epidemic on entering its second century. Tob Control. 2012;21:96–101.  https://doi.org/10.1136/tobaccocontrol-2011-050294.CrossRefPubMedGoogle Scholar
  7. 7.
    Maisonneuve P, Lowenfels AB. Risk factors for pancreatic cancer: a summary review of meta-analytical studies. Int J Epidemiol. 2015;44:186–98.  https://doi.org/10.1093/ije/dyu240.CrossRefPubMedGoogle Scholar
  8. 8.
    Scialpi M, Reginelli A, D’Andrea A, Gravante S, Falcone G, Baccari P, et al. Pancreatic tumors imaging: an update. Int J Surg. 2016;28(Suppl 1):S142–55.  https://doi.org/10.1016/j.ijsu.2015.12.053.CrossRefPubMedGoogle Scholar
  9. 9.
    Kupka K. International classification of diseases: ninth revision. WHO Chron. 1978;32:219–25.PubMedGoogle Scholar
  10. 10.
    Ashley J. The international classification of diseases: the structure and content of the tenth revision. Health Trends. 1990–1991;22:135–7.Google Scholar
  11. 11.
    Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961–2010. Cancer Epidemiol. 2014;38:227–324.  https://doi.org/10.1016/j.canep.2014.03.010.CrossRefPubMedGoogle Scholar
  12. 12.
    Urban D, Rao A, Bressel M, Lawrence YR, Mileshkin L. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Br J Cancer. 2013;109:1318–24.  https://doi.org/10.1038/bjc.2013.386.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Popat K, McQueen K, Feeley TW. The global burden of cancer. Best Pract Res Clin Anaesthesiol. 2013;27:399–408.  https://doi.org/10.1016/j.bpa.2013.10.010.CrossRefPubMedGoogle Scholar
  14. 14.
    Sidney S, Quesenberry Jr CP, Jaffe MG, Sorel M, Nguyen-Huynh MN, Kushi LH, et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiol. 2016;1:594–9.  https://doi.org/10.1001/jamacardio.2016.1326.CrossRefPubMedGoogle Scholar
  15. 15.
    Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–21.  https://doi.org/10.1158/0008-5472.CAN-14-0155.CrossRefGoogle Scholar
  16. 16.
    Ferlay J, Partensky C, Bray F. More deaths from pancreatic cancer than breast cancer in the EU by 2017. Acta Oncol. 2016;55:1158–60.  https://doi.org/10.1080/0284186X.2016.1197419.CrossRefGoogle Scholar
  17. 17.
    Jiao L, Li D. The nature of pancreatic cancer: epidemiology and prospects for prevention of pancreatic cancer. In: Pancreatic cancer. Ed(s) JP Neoptolemos, R Urrutia, JL Abbruzzese, MW Büchler (eds.). Springer 2010 New York.Google Scholar
  18. 18.
    Stolzenberg-Solomon RZ, Amundadottir LT. Epidemiology and inherited predisposition for sporadic pancreatic adenocarcinoma. Hematol Oncol Clin North Am. 2015;29:619–40.  https://doi.org/10.1016/j.hoc.2015.04.009.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Solomon S, Das S, Brand R, Whitcomb DC. Inherited pancreatic cancer syndromes. Cancer J. 2012;18:485–91.  https://doi.org/10.1097/PPO.0b013e318278c4a6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Risch HA, Lu L, Wang J, Zhang W, Ni Q, Gao YT, et al. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol. 2013;177:1326–37.  https://doi.org/10.1093/aje/kws458.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbeck’s Arch Surg. 2008;393:535–45.  https://doi.org/10.1007/s00423-007-0266-2.CrossRefGoogle Scholar
  22. 22.
    Tramacere I, Scotti L, Jenab M, Bagnardi V, Bellocco R, Rota M, et al. Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation. Int J Cancer. 2010;126:1474–86.  https://doi.org/10.1002/ijc.24936.CrossRefPubMedGoogle Scholar
  23. 23.
    Genkinger JM, Spiegelman D, Anderson KE, Bernstein L, van den Brandt PA, Calle EE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129:1708–17.  https://doi.org/10.1002/ijc.25794.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015;349:g7371.  https://doi.org/10.1136/bmj.g7371.CrossRefGoogle Scholar
  25. 25.
    Batabyal P, Vander Hoorn S, Christophi C, Nikfarjam M. Association of diabetes mellitus and pancreatic adenocarcinoma: a meta-analysis of 88 studies. Ann Surg Oncol. 2014;21:2453–62.  https://doi.org/10.1245/s10434-014-3625-6.CrossRefPubMedGoogle Scholar
  26. 26.
    Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P. Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomark Prev. 2005;14:1908–16.CrossRefGoogle Scholar
  27. 27.
    Gandini S, Puntoni M, Heckman-Stoddard BM, Dunn BK, Ford L, DeCensi A, et al. Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders. Cancer Prev Res (Phila). 2014;7:867–85.  https://doi.org/10.1158/1940-6207.CAPR-13-0424.CrossRefGoogle Scholar
  28. 28.
    Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol. 2010;24:349–58.  https://doi.org/10.1016/j.bpg.2010.02.007.CrossRefPubMedGoogle Scholar
  29. 29.
    Schulte A, Pandeya N, Fawcett J, Fritschi L, Risch HA, Webb PM, et al. Association between helicobacter pylori and pancreatic cancer risk: a meta-analysis. Cancer Causes Control. 2015;26:1027–35.  https://doi.org/10.1007/s10552-015-0595-3.CrossRefPubMedGoogle Scholar
  30. 30.
    Luo G, Hao NB, Hu CJ, Yong X, Lü MH, Cheng BJ, et al. HBV infection increases the risk of pancreatic cancer: a meta-analysis. Cancer Causes Control. 2013;24:529–37.  https://doi.org/10.1007/s10552-012-0144-2.CrossRefPubMedGoogle Scholar
  31. 31.
    Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19:4234–41.  https://doi.org/10.3748/wjg.v19.i26.4234.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Lin G, Zeng Z, Wang X, Wu Z, Wang J, Wang C, et al. Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies. Cancer Causes Control. 2012;23:59–67.  https://doi.org/10.1007/s10552-011-9856-y.CrossRefPubMedGoogle Scholar
  33. 33.
    Paluszkiewicz P, Smolińska K, Dębińska I, Turski WA. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case-control and cohort studies. Cancer Epidemiol. 2012;36:60–7.  https://doi.org/10.1016/j.canep.2011.05.004.CrossRefPubMedGoogle Scholar
  34. 34.
    Larsson SC, Wolk A. Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer. 2012;106:603–7.  https://doi.org/10.1038/bjc.2011.585.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Wu QJ, Wu L, Zheng LQ, Xu X, Ji C, Gong TT. Consumption of fruit and vegetables reduces risk of pancreatic cancer: evidence from epidemiological studies. Eur J Cancer Prev. 2016;25:196–205.  https://doi.org/10.1097/CEJ.0000000000000171.CrossRefPubMedGoogle Scholar
  36. 36.
    Lin HL, An QZ, Wang QZ, Liu CX. Folate intake and pancreatic cancer risk: an overall and dose-response meta-analysis. Public Health. 2013;127:607–13.  https://doi.org/10.1016/j.puhe.2013.04.008.CrossRefPubMedGoogle Scholar
  37. 37.
    Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, Bergkvist L, et al. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomark Prev. 2012;21:305–18.  https://doi.org/10.1158/1055-9965.EPI-11-0945-T.CrossRefGoogle Scholar
  38. 38.
    Shen QW, Yao QY. Total fat consumption and pancreatic cancer risk: a meta-analysis of epidemiologic studies. Eur J Cancer Prev. 2015;24:278–85.  https://doi.org/10.1097/CEJ.0000000000000073.CrossRefPubMedGoogle Scholar
  39. 39.
    Genkinger JM, Wang M, Li R, Albanes D, Anderson KE, Bernstein L, et al. Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Ann Oncol. 2014;25:1106–15.  https://doi.org/10.1093/annonc/mdu019.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Pelucchi C, Bosetti C, Galeone C, La Vecchia C. Dietary acrylamide and cancer risk: an updated meta-analysis. Int J Cancer. 2015;136:2912–22.  https://doi.org/10.1002/ijc.29339.CrossRefPubMedGoogle Scholar
  41. 41.
    Qin B, Xun P, He K. Fish or long-chain (n-3) PUFA intake is not associated with pancreatic cancer risk in a meta-analysis and systematic review. J Nutr. 2012;142:1067–73.  https://doi.org/10.3945/jn.111.156711.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Choi Y, Giovannucci E, Lee JE. Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a meta-analysis. Br J Nutr. 2012;108:1934–47.  https://doi.org/10.1017/S0007114512003984.CrossRefPubMedGoogle Scholar
  43. 43.
    Burkey MD, Feirman S, Wang H, Choudhury SR, Grover S, Johnston FM. The association between smokeless tobacco use and pancreatic adenocarcinoma: a systematic review. Cancer Epidemiol. 2014;38:647–53.  https://doi.org/10.1016/j.canep.2014.08.010.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Zhou J, Wellenius GA, Michaud DS. Environmental tobacco smoke and the risk of pancreatic cancer among non-smokers: a meta-analysis. Occup Environ Med. 2012;69:853–7.  https://doi.org/10.1136/oemed-2012-100844.CrossRefPubMedGoogle Scholar
  45. 45.
    Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M. Comparative risk assessment collaborating group (Cancers). Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005;366:1784–93.CrossRefGoogle Scholar
  46. 46.
    International Agency for Research on Cancer, Académie des Sciences-Institut de France, Académie de Médecine, Fédération Nationale des Centres de Lutte contre le Cancer. Attributable causes of cancer in France in the year 2000, IARC working group reports, vol. 3. Lyon: IARC Press; 2007.Google Scholar
  47. 47.
    Laffoy M, McCarthy T, Mullen L, Byrne D, Martin J. Cancer incidence and mortality due to alcohol: an analysis of 10-year data. Ir Med J. 2013;106:294–7.PubMedGoogle Scholar
  48. 48.
    Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91.CrossRefGoogle Scholar
  49. 49.
    Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011;105(Suppl 2):S77–81.  https://doi.org/10.1038/bjc.2011.489.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Schüz J, Espina C, Villain P, Herrero R, Leon ME, Minozzi S, et al. Working groups of scientific experts. European code against cancer 4th Edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39(Suppl 1):S1–10.  https://doi.org/10.1016/j.canep.2015.05.009.CrossRefPubMedGoogle Scholar
  51. 51.
    Jiao L, Mitrou PN, Reedy J, Graubard BI, Hollenbeck AR, Schatzkin A, et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med. 2009;169:764–70.  https://doi.org/10.1001/archinternmed.2009.46.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Division of Epidemiology and BiostatisticsEuropean Institute of OncologyMilanItaly
  2. 2.Department of Surgery and Department of Community and Preventive MedicineNew York Medical CollegeValhallaUSA

Section editors and affiliations

  • Raul A. Urrutia
    • 1
  • Markus W. Büchler
    • 2
  • John Neoptolemos
    • 3
  1. 1.Mayo Clinic Cancer CenterMayo ClinicRochesterUSA
  2. 2.Department of General, Visceral and Transplantation SurgeryUniversity of HeidelbergHeidelbergGermany
  3. 3.Division of Surgery and OncologyUniversity of LiverpoolLiverpoolUK

Personalised recommendations